Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Recovery article

PT-141 and Cialis | A Comprehensive Comparison

Curious about how PT-141 and Cialis interact with each other? Below, researchers will find everything they must know about these potent treatments. PT-141 is commonly known as bremelanotide, and has been approved under that name by the United States Food and D

Curious about how PT-141 and Cialis interact with each other?

Below, researchers will find everything they must know about these potent treatments.

PT-141 is commonly known as bremelanotide, and has been approved under that name by the United States Food and Drug Administration as a treatment of libido issues in premenopausal women.

Yet researchers are now studying the peptide as a potential treatment of sexual dysfunction in men, including conditions like erectile dysfunction and lack of sexual desire.

On the other hand, tadalafil (Cialis) is one of the most popular erectile dysfunction medications on the market, and has been FDA approved since 2003.

Researchers investigating male sexual disorders might want to learn more about:

How both PT-141 and Cialis influence the body?

Is PT-141 a safer option than Cialis?

Is it safe to administer PT-141 and Cialis concurrently?

Read on for answers to these questions, as well as whether in injectable form or as a nasal spray works better for the research.

Buy PT-141 from our top-rated vendor...

Disclaimer: Peptides.org contains information about products that are intended for laboratory and research use only, unless otherwise explicitly stated. This information, including any referenced scientific or clinical research, is made available for educational purposes only. Likewise, any published information relative to the dosing and administration of reference materials is made available strictly for reference and shall not be construed to encourage the self-administration or any human use of said reference materials. Peptides.org makes every effort to ensure that any information it shares complies with national and international standards for clinical trial information and is committed to the timely disclosure of the design and results of all interventional clinical studies for innovative treatments publicly available or that may be made available. However, research is not considered conclusive. Peptides.org makes no claims that any products referenced can cure, treat or prevent any conditions, including any conditions referenced on its website or in print materials.

What is PT-141?

PT-141 is a peptide analog of α-Melanocyte-stimulating hormone (α-MSH), an endogenous melanotropin known for its roles in stimulating melanogenesis and modulating sexual activity [1].

The peptide is known to have high affinity at the melanocortin 3 and 4 receptors (MC3-R and MC4-R), which are widely expressed in the brain and associated with aphrodisiac effects.

PT-141 thus works differently from approved erectile dysfunctions medications like Cialis, which work by stimulating blood flow to the penis via vasodilation. On the contrary, PT-141 sends signals directly to the neuronal connections responsible for arousal in both men and women.

The peptide was first developed by Palatin Technologies, and in the United States is today prescribed under the trade name Vyleesi, an injection-based treatment of hypoactive sexual desire disorder (HSDD) in premenopausal women [2, 3].

Benefits of PT-141

While PT-141 has been approved to treat HSDD in premenopausal women, research has shown that this peptide can provide benefits in male subjects who suffer from conditions like erectile dysfunction and low libido.

PT-141 as an Alternative to PDE5 Inhibiting Treatments

In a PT-141 study conducted back in 2004, researchers sought to determine the effects of this peptide in ED patients who were unable to achieve erections suitable for vaginal penetration despite taking the PDE5 inhibitor Viagra (sildenafil). The researchers found a statistically significant erectile response in these patients at PT-141 doses of 4mg and 6mg. The authors concluded that PT-141 was safe and well-tolerated and proposed the peptide as an ED treatment with a “potentially broad patient base” [4].

Two years later in 2006, Iranian researchers similarly conducted a study on 342 men with ED who did not respond to sildenafil. The patients were instructed to intranasally self-administer PT-141 doses of 10mg each, 45 minutes to two hours before sexual stimulation. The patients who received PT-141 experienced “significantly greater intercourse satisfaction” compared to placebo [5].

PT-141 May Positively Impact Mood and Well-being

Melanocortin peptides have been shown to facilitate the neurotransmission of dopamine. A two-week study conducted on rodents showed changes in dopamine D(1)-like receptor binding in various sections of the rodents’ brains as a result of intracerebroventricular infusion of melanotan 2, from which PT-141 was originally developed [6].

The authors suggested that changes in dopaminergic neurons can be achieved by chronic infusion of a melanocortin receptor agonist, and that a greater sense of well-being can result from the regulatory activity of melanocortin peptides such as PT-141 on central dopamine neurons [6].

PT-141 Induces Sexual Desire in Female Subjects With Low Libido

As we mentioned, PT-141 (bremelanotide) is already approved to treat libido issues in premenopausal women. A 52-week trial on the safety and efficacy of bremelanotide, involving 856 premenopausal women with HSDD, has demonstrated that PT-141 treatment led to “sustained improvements in hypoactive sexual desire disorder symptoms” in the female patients [7].

What is Cialis?

Cialis is a brand name for the prescription drug tadalafil, a selective phosphodiesterase type 5 inhibitor used to treat men with mild to severe erectile dysfunction (ED), including those with diabetes mellitus. It works by selectively inhibiting cGMP-specific phosphodiesterase type 5 (PDE5), which is found in all vascular tissue [8, 9].

It is also approved by the U.S. Food and Drug Administration to treat symptoms of benign prostatic hyperplasia (BPH), which is age-related of the prostate gland that can cause problems with urination. Tadalafil is also used as a long-term treatment of pulmonary arterial hypertension pulmonary arterial hypertension (PAH) in the US, Canada, and Japan [9].

Cialis is typically self-administered orally as a tablet at varying strengths of 2.5mg, 5mg, 10mg, or 20mg. Its effects may last up to 36 hours [10].

While generally regarded as safe, Cialis has been shown to produce mild to moderate adverse effects, with the most commonly reported being headache, dyspepsia, back pain, and myalgia [8, 10, 11].

In a safety study involving 400+ men, both healthy and men with ED, researchers investigated the potential of tadalafil to affect spermatogenesis or reproductive hormones. The researchers found that daily administration of tadalafil at doses of 10mg and 20mg over six months did not have any effect on spermatogenesis or reproductive hormones in the men [11].

Benefits of Cialis

In addition to its use as an erectile dysfunction treatment, Cialis may produce a number of other benefits in men, which we outline below.

Cialis and Prostate Health

It is well-established in the literature that Cilalis (tadalafil) is effective in treating benign prostatic hyperplasia (BPH), or age-associated enlargement of the prostate gland. In cases of lower urinary tract symptoms or enlarged prostate, tadalafil’s action as a PDE5 inhibitor and resultant changes in NO/cGMP signaling, has the effect of relaxing prostatic smooth muscle and thus mitigating urethral pressure. Daily administration of a dose of 5mg of Cialis yields statistically significant improvements in both BPH and ED symptoms in men suffering from either both conditions [12, 13].

Cialis Increases Vascularity and Blood Flow

In a four-week study back in 2006, Italian researchers sought to investigate whether Cialis could improve endothelium-dependent vasodilatation of cavernous arteries in ED patients, and whether this would be borne out in endothelial function markers. The researchers found that 20mg of tadalafil administered on alternate days produced an increase in peak systolic velocity (PSV) and flow-mediated dilatation (FMD) in the men, with improvements being maintained from two weeks after discontinuation [14].

Cialis Improves the Testosterone to Estrogen Ratio

In another early Italian study, researchers sought to determine whether tadalafil could cause positive long-term changes in the sex hormones of ED patients, due to their resumption of sexual activity thanks to tadalafil. In the study, 20 patients received tadalafil 10-20 mg on demand for 12 months. They ultimately showed sustained improvement in sexual health due to an increased testosterone to estrogen ratio, mainly thanks to estrogen reduction.

The researchers surmised that tadalafil achieved this effect by preventing the enzyme aromatase from converting testosterone to estrogen, thus helping patients attain a more optimized testosterone to estrogen ratio [15].

Cialis Can Improve Relationship Satisfaction

A 12-month study in 1900 erectile dysfunction patients showed that Cialis could improve the relationships of couples. Prior to the men being given Cialis, 17% of the couples had reported relationship problems. Following 12 months of Cialis administration, only 4% of participants reported relationship problems. This study indicated that erectile dysfunction is a cause of relationship problems, and that introducing Cialis can overcome ED and thus improve relationship satisfaction [16].

PT-141 and Cialis | Can They Be Taken Together?

Since PT-141 and PDE5 inhibitors like Cialis can potentially boost male libido and mood, researchers may be interested in co-administering these compounds to study their combined effects.

However, there are no studies that have determined the effects of PT-141 specifically being coadministered with Cialis.

Yet there is research on PT-141 being co-administered with Viagra, another PDE5 inhibitor that works similarly to Cialis. While the two have different pharmacokinetics profiles, experts state that tadalafil is “not really distinguishable from sildenafil in terms of efficacy and side effects” [17].

In a study conducted on nineteen male patients with erectile dysfunction, researchers directed the volunteers to self-administer both Viagra 25mg and PT-141 7.5mg intranasally. The researchers found that co-administration of PT-141 and sildenafil produced a more profound erectile response than administering sildenafil alone. Importantly, the coadministration of the two compounds was safe and well-tolerated and did not result in any new adverse events [18].

This study opens up the door to the co-administration of Cialis and PT-141, which may yield a similar outcome.

PT-141 vs. Cialis

PT-141 and Cialis have both been noted for their effects on alleviating symptoms of erectile dysfunction. However, the two have different mechanisms of action, methods of administration, and contraindications:

Cialis inhibits the enzyme phosphodiesterase 5 (PDE5), which causes decomposition of cGMP, thus regulating the circulation of blood to the penis. On the other hand, PT-141 binds primarily to the melanocortin receptors MC3R and MC4R, which regulate motivation for sex and sexual arousal [19].

In simple terms, PT-141 acts via the central nervous system to incite arousal, while Cialis can only function to deliver a stronger erection if arousal is already present.

Cialis is typically self-administered in capsule form, while PT-141 may either be injected subcutaneously or administered intranasally.

Cialis should not be administered alongside nitrate drugs for chest pain or heart problems, like nitroglycerin, isosorbide dinitrate, isosorbide mononitrate. It should not be taken with alcohol. On the other hand, PT-141 is contraindicated in patients with uncontrolled hypertension or known cardiovascular disease [20, 21].

Where To Buy PT-141 Online? | 2024 Edition

Licensed researchers and laboratory professionals may purchase PT-141 online for scientific pursuits. While there are a number of peptide vendors to choose from, not all are created equally.

For example, some vendors take peptide quality very seriously and submit all of their products to a third-party laboratory for quality and purity testing. Others, however, do not take these measures, and instead send out peptides of dubious quality.

At Peptides.org, we’re insiders of the research peptides community, and know exactly which vendors to buy from, and which to avoid. Here is our favorite pick:

Limitless Life

Researchers in search of high-quality PT-141 may check out Limitless Life, a trusted leader within the research peptides community.

This vendor is known for:

Independent Lab Testing: The company sends each batch of PT-141 to an independent laboratory for quality and purity testing via high performance liquid chromatography and mass spectrometry (HPLC-MS). Limitless Life produces some of the purest research peptides around.

Fast Shipping: Shipping is lightning fast, with most domestic orders taking just two to three business days to arrive. This is because Limitless Life offers FedEx two-day shipping standard. What’s more, orders over $350 qualify for free shipping.

Researcher Support and Service: Limitless Life’s professional support and service team is available to answer any inquiry by phone or email. This makes it simple for researchers to get questions answered on the fly.

Fantastic Return and Reship Options: Limitless Life understands the needs of the research community. As such, the vendor has developer a flexible return and reship policy. This ensures researchers are sure to get their peptides no matter what. They also offer affordable shipping insurance to offer researchers peace of mind.

Responsible Research-Use Only Source: Limitless Life peptides and products are for research purposes only. The vendor prides themselves on working within the research community. This unique approach shows their commitment to responsible distribution or research peptides, which ensures safety for researchers.

Also, don't forget one more thing when buying PT-141 online…

Limitless Life offers researchers a 10% discount on the next order using our exclusive link. Just click the button below and add this code:

peptidesorg10

Nasal Spray vs. Injectable PT-141

By now, researchers are likely aware that PT-141 peptide may be administered either via subcutaneous injection or as a nasal spray.

Some researchers may prefer a PT-141 spray due its ease of administration and portability, since a PT-141 in spray form is already reconstituted and does not need to be prepared for injection. Most PT-141 nasal spray formulas need not even be refrigerated, unlike injectable PT-141.

A PT-141 nasal spray may also produce a slightly faster response in the patient, compared to subcutaneous administration. However, any discrepancy is likely to be minimal, seeing as both the Vyleesi manufacturer of the injectable formulation and research studies conducted using PT-141 nasal sprays recommend administering PT-141 about 45 minutes prior to sexual intercourse [5, 21].

The gold standard form of PT-141 administration remains subcutaneous administration. However, studies have shown that a research-grade nasal spray may be equally as effective.

Researchers who may benefit from the convenience of a PT-141 nasal spray should visit Limitless Life.

Limitless Life offers a top-notch PT-141 spray which contains 50mg PT-141, which is potent and powerful enough to compete with aliquot PT-141 powders. This is very rare, but quite impressive.

Buy PT-141 Nasal Spray from our top-rated vendor...

Bacteriostatic Water and PT-141

There is no getting around the need for certain lab supplies when handling PT-141 and all other research peptides. To safely and correctly administer peptides, a researcher must be equipped with a standard set of essential items.

What should be in this toolkit? Required materials include alcohol swabs and bacteriostatic water, among others.

Overall, a research lab may require supplies and materials like:

Bacteriostatic Water

Insulin Syringes

Alcohol Prep Pads

Sterile Empty Glass Vials

Large Needles + Syringes

It should be noted that…

Researchers opting for PT-141 nasal spray do not need to acquire such materials for their labs.

Cialis and PT-141 | Verdict

PT-141 and Cialis may both be used to address male sexual dysfunction during research, yet these two compounds have different methods of action and administration.

While Cialis has been approved by the FDA to treat erectile dysfunction, among other conditions, PT-141 still only has FDA approval to treat low libido in premenopausal women.

However, there is extensive literature that illustrates the benefits that PT-141 may offer to male research subjects, most notably to those with erectile dysfunction who do not respond to Viagra, which like Cialis is a PDE5 inhibitor.

Researchers interested in exploring this massive upside of PT-141 should visit Limitless Life for both injectable and spray variations of PT-141.

CONNECTED / MODULES

Post-session references

Selected from shared article topics. Source links are retained where available.

01

Handling & safety lane

Source-derived education, not individual medical guidance or an instruction to dose.

DOSAGE SOURCE

How Dosing Protocol Affects One-Month Outcomes

PT-141 results after 1 month are directly influenced by dosing frequency and timing relative to anticipated sexual activity. The FDA-approved protocol for premenopausal women with hypoactive sexual desire disorder recommends 1.75mg subcutaneous injection at least 45 minutes before anticipated sexual activity, with a maximum of one dose per 24 hours and eight doses per month. Research participants who adhered to this schedule showed 2–3× higher response rates than those who dosed irregularly. The peptide's pharmacokinetics create a therapeutic window that peaks 1–3 hours post-injection, but the psychological effects. Increased desire, heightened mental arousal. Can persist for 6–12 hours in responsive individuals. This is mechanistically different from on-demand erectogenic agents: PT-141 doesn't create arousal in the absence of sexual stimuli, but it amplifies responsiveness to existing stimuli by lowering the activation threshold in melanocortin pathways. Our team has found that participants who front-load dosing during the first two weeks (3 doses in week 1, 2–3 doses in week 2) report earlier onset of subjective effects compared to those who start with once-weekly administration. This suggests that initial receptor saturation may accelerate the pathway recalibration process, though no published trials have formally tested front-loading protocols.
SIDE EFFECTS

Common Side Effects

The most frequently reported PT-141 side effects emerge from comprehensive Phase 3 clinical trials involving 1,267 women receiving the FDA-approved 1.75mg subcutaneous dose.[1] These common adverse events typically manifest within 2-4 hours of injection and resolve within 24-72 hours without medical intervention. Nausea 40% 1-3 hours 4-8 hours Mild to moderate Flushing 20% 30-60 minutes 2-4 hours Mild Injection site reactions 20-25% Immediate 24-48 hours Headache 15% 6-12 hours Vomiting 13% 1-4 hours 2-6 hours Hot flashes 11% 1-2 hours 3-6 hours Fatigue 8% 12-24 hours Nausea represents the most significant tolerability challenge, affecting 40% of patients compared to 1% in placebo groups.[1] This gastrointestinal side effect typically peaks 2-3 hours post-injection and correlates with peak plasma concentrations of 2.3 ng/mL achieved at 30-60 minutes.[3] The nausea response demonstrates dose-dependency, with 1.25mg doses producing 28% incidence rates versus 52% at 2.0mg doses in dose-ranging studies.[4] Injection site reactions manifest as erythema, swelling, or mild pain at the subcutaneous administration site, affecting 20-25% of users.[1] These local reactions typically resolve within 24-48 hours and can be minimized through proper injection site rotation between the abdomen and thigh. The 27-gauge needle recommended for PT-141 administration produces lower injection site reaction rates compared to larger gauge needles used in earlier clinical development.[3] Flushing occu…
02

Question drills

Open a question for its connected answer.

01What If Intranasal PT-141 Causes Severe Nausea in a Research Subject?+

Administer ondansetron 4–8mg orally 30 minutes before the next dose. 5-HT3 antagonists reduce nausea incidence to <15% without interfering with melanocortin receptor binding. Nausea from PT-141 is mediated by MC4R activation in the area postrema (the brain's chemoreceptor trigger zone), which ondansetron does not block, so the antiemetic effect is purely symptomatic. If nausea persists despite pre-treatment, reduce the dose by 25–30% rather than discontinuing. Nausea severity scales non-linearly with dose, and a 1.25mg dose produces 60% less emetic signalling than 1.75mg while maintaining >80% of the melanocortin receptor activation.

SOURCE / realpeptides.co ↗
02What If the Patient Has Controlled Hypertension on Medication?+

Monitor blood pressure before and 1–2 hours after the first PT-141 injection to assess individual response. Bremelanotide produced mean systolic increases of 2–3 mmHg in normotensive trial participants—patients with controlled hypertension (systolic <140 mmHg on stable medication regimen) were not excluded from trials and did not demonstrate significantly higher cardiovascular event rates. Uncontrolled hypertension (systolic ≥140 mmHg) is a contraindication due to theoretical risk of hypertensive crisis or cardiovascular ischemia. The peptide's vasoconstrictive melanocortin effects are transient, peaking within 1–3 hours and resolving by 6 hours post-injection.

SOURCE / realpeptides.co ↗
03What If PT-141 Works for Me But I Want to Use It More Than Twice Weekly?+

Limit dosing to no more than once every 72 hours. Melanocortin receptors undergo desensitization with frequent agonist exposure. Receptor internalization and downregulation reduce responsiveness over time. Patients who dose more frequently report diminished subjective effects within 2–3 weeks. Spacing doses maintains receptor sensitivity and ensures consistent therapeutic benefit. If twice-weekly use isn't sufficient, consider combining PT-141 with behavioral interventions or adjusting the timing to prioritize high-value opportunities.

SOURCE / realpeptides.co ↗
04What If My PT-141 Turned Cloudy Immediately After Mixing?+

Discard the vial and do not inject. Immediate cloudiness upon reconstitution indicates one of three failures: the lyophilised powder was already degraded before mixing (from improper storage or an expired vial), the bacteriostatic water used for reconstitution was contaminated or had incorrect pH, or the reconstitution technique introduced contaminants into the solution. Peptides that cloud immediately have undergone rapid protein aggregation and carry no therapeutic benefit. Check your remaining lyophilised vials for proper storage conditions (they should have been kept at −20°C) and verify your bacteriostatic water has not expired and was stored correctly at room temperature in a sterile, sealed container.

SOURCE / realpeptides.co ↗
05What If I Get Strong Flushing or Nasal Congestion — Does That Mean It's Working?+

Flushing and nasal congestion confirm that PT-141 is pharmacologically active and binding to melanocortin receptors in peripheral vascular tissue. These are valid biomarkers of peptide integrity, but they are not proxies for sexual desire. The same receptor activation that causes facial warmth also occurs in the hypothalamus, but the central effects (libido enhancement) develop on a slower timeline than peripheral effects (vasodilation). If flushing is uncomfortable, it typically diminishes with repeated dosing as peripheral receptors downregulate.

SOURCE / realpeptides.co ↗
03

Evidence cooldown

Research context and source excerpts for a slower second read.

RESEARCH

Sepsis-Related Cardiovascular Research: MC Anti-Inflammatory Cytoprotection

Septic cardiomyopathy — cardiac dysfunction complicating sepsis through inflammatory cytokine-mediated cardiomyocyte apoptosis, mitochondrial dysfunction, and calcium handling impairment — represents a cardiovascular research area where melanocortin anti-inflammatory biology is mechanistically relevant. LPS-induced cardiomyopathy in rodents (10mg/kg LPS i.p. in C57BL/6; echocardiography LVEF assessment at 6h, 12h, 24h) produces reproducible cardiac dysfunction with elevated troponin, reduced LVEF, and cardiac IL-6/TNF-α/IL-1β elevation. Alpha-MSH and melanocortin agonists have established cytoprotective effects in LPS cardiac models through MC1R/MC3R-cAMP-NF-κB inhibition in cardiomyocytes and macrophages, reduced NLRP3-IL-1β inflammasome activation, and eNOS-NO preservation. PT-141 as an MC agonist in LPS cardiomyopathy uses the same mechanistic framework with the pharmacological advantage of peptide stability (cyclic structure; t½ >60 minutes in rodents versus <5 minutes for linear α-MSH) and oral bioavailability potential.

RESEARCH

Research Disclaimer

PT-141 is a research chemical not approved for human consumption. Storage and handling guidance is provided for laboratory research purposes. Researchers must comply with institutional safety protocols, relevant legislation, and ethical guidelines when handling PT-141 in research contexts. 🔗 Related Reading: For a comprehensive overview of PT-141 research, mechanisms, UK sourcing, and safety data, see our PT-141 (Bremelanotide) UK: Complete Research Guide (2026). William is a research analyst at Peptides Lab UK, specialising in research peptides, laboratory compounds, and sourcing standards for high-purity peptide products.

05

Product & matchup locker

Linked catalog and comparison files.